Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

Radiological and pathological features of orbital cranial fasciitis.

Ginat DT, Pytel P, Horowitz PM.

Orbit. 2019 Sep 11:1. doi: 10.1080/01676830.2019.1658791. [Epub ahead of print] No abstract available.

PMID:
31509037
2.

An overview of meningiomas.

Buerki RA, Horbinski CM, Kruser T, Horowitz PM, James CD, Lukas RV.

Future Oncol. 2018 Sep;14(21):2161-2177. doi: 10.2217/fon-2018-0006. Epub 2018 Aug 7. Review.

3.

Combined petrosal approach.

Polster SP, Horowitz PM, Awad IA, Gluth MB.

Curr Opin Otolaryngol Head Neck Surg. 2018 Oct;26(5):293-301. doi: 10.1097/MOO.0000000000000480. Review.

PMID:
30045103
4.

Diagnostic Evaluation in Primary CNS Lymphoma.

Lukas RV, Riedell P, Horowitz PM, Pytel P, Kamson DO.

Neurologist. 2018 Mar;23(2):53-54. doi: 10.1097/NRL.0000000000000169.

PMID:
29494436
5.

MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism.

Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, Silva A, Boucher K, Henn RE, Kang YJ, Knoff D, Paolella BR, Gladden-Young A, Varlet P, Pages M, Horowitz PM, Federation A, Malkin H, Tracy AA, Seepo S, Ducar M, Van Hummelen P, Santi M, Buccoliero AM, Scagnet M, Bowers DC, Giannini C, Puget S, Hawkins C, Tabori U, Klekner A, Bognar L, Burger PC, Eberhart C, Rodriguez FJ, Hill DA, Mueller S, Haas-Kogan DA, Phillips JJ, Santagata S, Stiles CD, Bradner JE, Jabado N, Goren A, Grill J, Ligon AH, Goumnerova L, Waanders AJ, Storm PB, Kieran MW, Ligon KL, Beroukhim R, Resnick AC.

Nat Genet. 2016 Mar;48(3):273-82. doi: 10.1038/ng.3500. Epub 2016 Feb 1.

6.

Awake Craniotomy and Intraoperative MRI for Maximal Safe Resection in a Case of an Extensive Left Frontal and Insular Low-grade Glioma: 3-Dimensional Operative Video.

Abolfotoh M, Horowitz PM, Chiocca EA.

Oper Neurosurg (Hagerstown). 2015 Dec 1;11(4):578. doi: 10.1227/NEU.0000000000000966. No abstract available.

PMID:
29506174
7.

Complication Avoidance in Endoscopic Skull Base Surgery.

Horowitz PM, DiNapoli V, Su SY, Raza SM.

Otolaryngol Clin North Am. 2016 Feb;49(1):227-35. doi: 10.1016/j.otc.2015.09.014. Review.

PMID:
26614840
8.

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.

Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT, Dunn IF, Paek SH, Park SH, McKenna A, Chevalier A, Rosenberg M, Barker FG 2nd, Gill CM, Van Hummelen P, Thorner AR, Johnson BE, Hoang MP, Choueiri TK, Signoretti S, Sougnez C, Rabin MS, Lin NU, Winer EP, Stemmer-Rachamimov A, Meyerson M, Garraway L, Gabriel S, Lander ES, Beroukhim R, Batchelor TT, Baselga J, Louis DN, Getz G, Hahn WC.

Cancer Discov. 2015 Nov;5(11):1164-1177. doi: 10.1158/2159-8290.CD-15-0369. Epub 2015 Sep 26.

9.

Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.

Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, Cho YJ, Taha H, Mahmoud M, Bowers DC, Margraf L, Tabori U, Hawkins C, Packer RJ, Hill DA, Pomeroy SL, Eberhart CG, Dunn IF, Goumnerova L, Getz G, Chan JA, Santagata S, Hahn WC, Stiles CD, Ligon AH, Kieran MW, Beroukhim R, Ligon KL.

Proc Natl Acad Sci U S A. 2013 May 14;110(20):8188-93. doi: 10.1073/pnas.1300252110. Epub 2013 Apr 30.

10.

Nanotechnology-based strategies for the diagnosis and treatment of intracranial neoplasms.

Horowitz PM, Chiocca EA.

World Neurosurg. 2013 Jul-Aug;80(1-2):53-5. doi: 10.1016/j.wneu.2013.02.039. Epub 2013 Feb 14. No abstract available.

PMID:
23416779
11.

Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Brastianos PK, Horowitz PM, Santagata S, Jones RT, McKenna A, Getz G, Ligon KL, Palescandolo E, Van Hummelen P, Ducar MD, Raza A, Sunkavalli A, Macconaill LE, Stemmer-Rachamimov AO, Louis DN, Hahn WC, Dunn IF, Beroukhim R.

Nat Genet. 2013 Mar;45(3):285-9. doi: 10.1038/ng.2526. Epub 2013 Jan 20.

12.

Adult low-grade gliomas: surgery vs biopsy?

Horowitz PM, Chi J.

Neurosurgery. 2013 Feb;72(2):N19. doi: 10.1227/01.neu.0000426216.20454.22. No abstract available.

PMID:
23328659
13.

Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro.

Lapointe NE, Horowitz PM, Guillozet-Bongaarts AL, Silva A, Andreadis A, Binder LI.

Biochemistry. 2009 Dec 29;48(51):12290-7. doi: 10.1021/bi901304u.

14.

A possible link between astrocyte activation and tau nitration in Alzheimer's disease.

Reyes JF, Reynolds MR, Horowitz PM, Fu Y, Guillozet-Bongaarts AL, Berry R, Binder LI.

Neurobiol Dis. 2008 Aug;31(2):198-208. doi: 10.1016/j.nbd.2008.04.005. Epub 2008 May 2.

15.

Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro.

Sengupta S, Horowitz PM, Karsten SL, Jackson GR, Geschwind DH, Fu Y, Berry RW, Binder LI.

Biochemistry. 2006 Dec 19;45(50):15111-9.

PMID:
17154549
16.

N-terminal fragments of tau inhibit full-length tau polymerization in vitro.

Horowitz PM, LaPointe N, Guillozet-Bongaarts AL, Berry RW, Binder LI.

Biochemistry. 2006 Oct 24;45(42):12859-66.

PMID:
17042504
17.

Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.

Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, Horowitz PM, Fu Y, Wang T, Cahill ME, Bigio EH, Berry RW, Binder LI.

Neurobiol Aging. 2005 Jul;26(7):1015-22. Epub 2004 Dec 16.

PMID:
15748781
18.

Prodan fluorescence mimics the GroEL folding cycle.

Kaur Y, Horowitz PM.

Protein J. 2004 Oct;23(7):475-81.

PMID:
15635940
19.

Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.

Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, Reynolds MR, Carroll CA, Weintraub ST, Bennett DA, Cryns VL, Berry RW, Binder LI.

J Neurosci. 2004 Sep 8;24(36):7895-902.

20.

Active rhodanese lacking nonessential sulfhydryl groups has increased hydrophobic exposure not observed in wild-type enzyme.

Kaur Y, Ybarra J, Horowitz PM.

Protein J. 2004 May;23(4):255-61. Erratum in: Protein J. 2004 Oct;23(7):493.

PMID:
15214496
22.

Active rhodanese lacking nonessential sulfhydryl groups contains an unstable C-terminal domain and can be bound, inactivated, and reactivated by GroEL.

Ybarra J, Bhattacharyya AM, Panda M, Horowitz PM.

J Biol Chem. 2003 Jan 17;278(3):1693-9. Epub 2002 Nov 13.

23.

Dissociation of the single-ring chaperonin GroEL by high hydrostatic pressure.

Panda M, Ybarra J, Horowitz PM.

Biochemistry. 2002 Oct 22;41(42):12843-9.

PMID:
12379127
24.

The molecular chaperone DnaK is not recruited to translating ribosomes that lack trigger factor.

Kramer G, Ramachandiran V, Horowitz PM, Hardesty B.

Arch Biochem Biophys. 2002 Jul 1;403(1):63-70.

PMID:
12061803
25.
26.
27.
29.
30.

The aggregation state of rhodanese during folding influences the ability of GroEL to assist reactivation.

Bhattacharyya AM, Horowitz PM.

J Biol Chem. 2001 Aug 3;276(31):28739-43. Epub 2001 Jun 7.

31.
32.

Active-site sulfhydryl chemistry plays a major role in the misfolding of urea-denatured rhodanese.

Panda M, Horowitz PM.

J Protein Chem. 2000 Jul;19(5):399-409.

PMID:
11131146
33.
34.

Rhodanese as a thioredoxin oxidase.

Nandi DL, Horowitz PM, Westley J.

Int J Biochem Cell Biol. 2000 Apr;32(4):465-73. Erratum in: Int J Biochem Cell Biol 2001 Jan;33(1):103.

PMID:
10762072
35.

Productive and nonproductive intermediates in the folding of denatured rhodanese.

Panda M, Gorovits BM, Horowitz PM.

J Biol Chem. 2000 Jan 7;275(1):63-70.

36.

Domain separation precedes global unfolding of rhodanese.

Shibatani T, Kramer G, Hardesty B, Horowitz PM.

J Biol Chem. 1999 Nov 19;274(47):33795-9.

37.

The hydrophobic properties of GroEL: a review of ligand effects on the modulation of GroEL hydrophobic surfaces.

Brazil BT, Horowitz PM.

Cell Stress Chaperones. 1999 Sep;4(3):177-90. Review. No abstract available.

38.
39.
40.

GroES in the asymmetric GroEL14-GroES7 complex exchanges via an associative mechanism.

Horowitz PM, Lorimer GH, Ybarra J.

Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2682-6.

41.

Ironing out the protein folding problem?

Horowitz PM.

Nat Biotechnol. 1999 Feb;17(2):136-7. No abstract available.

PMID:
10052346
42.

Truncations at the NH2 terminus of rhodanese destabilize the enzyme and decrease its heterologous expression.

Trevino RJ, Tsalkova T, Kramer G, Hardesty B, Chirgwin JM, Horowitz PM.

J Biol Chem. 1998 Oct 23;273(43):27841-7.

43.
44.

Photoincorporation of fluorescent probe into GroEL: defining site of interaction.

Seale JW, Brazil BT, Horowitz PM.

Methods Enzymol. 1998;290:318-23.

PMID:
9534172
45.

Fluorescence anisotropy method for investigation of GroEL-GroES interaction.

Gorovits BM, Horowitz PM.

Methods Enzymol. 1998;290:313-7. No abstract available.

PMID:
9534171
46.

Rhodanese folding is controlled by the partitioning of its folding intermediates.

Gorovits BM, McGee WA, Horowitz PM.

Biochim Biophys Acta. 1998 Jan 15;1382(1):120-8.

PMID:
9507086
48.
49.

Preformed GroES oligomers are not required as functional cochaperonins.

Seale JW, Chirgwin JM, Demeler B, Horowitz PM.

J Protein Chem. 1997 Oct;16(7):661-8.

PMID:
9330224
50.

Supplemental Content

Loading ...
Support Center